Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 05, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Albendazole Tablets USP, 200 mg".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 05, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Albendazole Tablets USP, 200 mg".